Acinic Cell Carcinoma - 45 Studies Found
| Completed |
: Sunitinib in Treating Patients With Metastatic Pancreatic Cancer That Progressed After First-Line Therapy With Gemcitabine :
|
| Active, not recruiting |
: GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors That Cannot Be Removed by Surgery :
: |
| Completed |
: Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer :
|
| Completed |
: CPI-613 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer :
|
| Active, not recruiting |
: Chemotherapy and Radiation Therapy Before Surgery Followed by Gemcitabine in Treating Patients With Pancreatic Cancer :
|
| Suspended |
: Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By Surgery :
|
| Completed |
: Sorafenib Tosylate and Everolimus in Treating Patients With Advanced Solid Tumors and Metastatic Pancreatic Cancer That Does Not Respond to Gemcitabine Hydrochloride :
|
| Completed |
: Triapine as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas :
|
| Completed |
: Paclitaxel and Bryostatin 1 in Treating Patients With Advanced Pancreatic Cancer :
|
| Recruiting |
: Nivolumab and Ipilimumab in Treating Patients With Rare Tumors :
|